NASDAQ:XRAYDENTSPLY SIRONA Stock Price, Forecast & News

$42.24

+0.28 (+0.67 %)

(As of 05/25/2020 04:00 PM ET)

Add

Compare

Today's Range

$40.63

Now: $42.24▼

$42.59

50-Day Range

$35.45

MA: $40.02▼

$44.20

52-Week Range

$31.58

Now: $42.24▼

$60.87

Volume2.02 million shs

Average Volume2.62 million shs

Market Capitalization$9.25 billion

P/E Ratio114.16

Dividend Yield0.95%

Beta1.03

DENTSPLY SIRONA Inc. designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers. The company also offers dental laboratory products, such as dental prosthetics that include artificial teeth, precious metal dental alloys, dental ceramics, and crown and bridge materials. In addition, it provides dental technology products, including dental implants and related scanning equipment, treatment software, and orthodontic appliances for dental practitioners and specialist, and dental laboratories; and dental equipment, such as treatment centers, imaging equipment, and computer aided design and machining systems for dental practitioners and laboratories. Further, the company offers healthcare consumable products, such as urology catheters, medical drills, and other non-medical products. It markets and sells dental products through distributors, dealers, and importers to dentists, dental hygienists, dental assistants, dental laboratories, and dental schools; and urology products directly to patients, as well as through distributors to urologists, urology nurses, and general practitioners. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in York, Pennsylvania.

Beat the Market (BTM) Rank^™

3.2 Analyst's Opinion

Consensus Rating
DENTSPLY SIRONA has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 4 buy ratings, 8 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $47.82, DENTSPLY SIRONA has a potential upside of 13.2% from its current price of $42.24.
Amount of Analyst Coverage
DENTSPLY SIRONA has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

2.4 Community Rank

Outperform Votes
DENTSPLY SIRONA has received 404 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
DENTSPLY SIRONA has received 442 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
DENTSPLY SIRONA has received 52.25% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about DENTSPLY SIRONA and other stocks. Vote “Outperform” if you believe XRAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe XRAY will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
DENTSPLY SIRONA is a leading dividend payer. It pays a dividend yield of 0.95%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
DENTSPLY SIRONA has been increasing its dividend for 8 years.
Dividend Coverage
The dividend payout ratio of DENTSPLY SIRONA is 16.33 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, DENTSPLY SIRONA will have a dividend payout ratio of 17.32 % next year. This indicates that DENTSPLY SIRONA will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, DENTSPLY SIRONA insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 0.62% of the stock of DENTSPLY SIRONA is held by insiders.
Percentage Held by Institutions
95.39% of the stock of DENTSPLY SIRONA is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9 Earnings and Valuation

Earnings Growth
Earnings for DENTSPLY SIRONA are expected to grow by 75.00% in the coming year, from $1.32 to $2.31 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of DENTSPLY SIRONA is 114.16, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 12.65.
Price to Earnings Ratio vs. Sector
The P/E ratio of DENTSPLY SIRONA is 114.16, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 19.91.
Price to Earnings Growth Ratio
DENTSPLY SIRONA has a PEG Ratio of 4.24. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
DENTSPLY SIRONA has a P/B Ratio of 1.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.52 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Dental equipment & supplies

Sub-IndustryHealth Care Supplies

SectorMedical

Current SymbolNASDAQ:XRAY

Previous Symbol

CUSIP24903010

CIK818479

Webwww.dentsplysirona.com

Phone844-546-3722

Debt

Debt-to-Equity Ratio0.33

Current Ratio2.02

Quick Ratio1.36

Price-To-Earnings

Trailing P/E Ratio114.16

Forward P/E Ratio32.00

P/E Growth4.24

Sales & Book Value

Annual Sales$4.03 billion

Price / Sales2.30

Cash Flow$3.94 per share

Price / Cash Flow10.73

Book Value$22.91 per share

Price / Book1.84

Profitability

EPS (Most Recent Fiscal Year)$2.45

Net Income$262.90 million

Net Margins2.12%

Return on Equity10.70%

Return on Assets6.38%

Miscellaneous

Employees15,200

Outstanding Shares219,080,000

Market Cap$9.25 billion

Next Earnings Date8/7/2020 (Estimated)

OptionableOptionable

Receive XRAY News and Ratings via Email

Sign-up to receive the latest news and ratings for XRAY and its competitors with MarketBeat's FREE daily newsletter.

DENTSPLY SIRONA (NASDAQ:XRAY) Frequently Asked Questions

How has DENTSPLY SIRONA's stock been impacted by COVID-19 (Coronavirus)?

DENTSPLY SIRONA's stock was trading at $42.56 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XRAY shares have decreased by 0.8% and is now trading at $42.24. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of DENTSPLY SIRONA?

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for DENTSPLY SIRONA in the last year. There are currently 8 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for DENTSPLY SIRONA.

When is DENTSPLY SIRONA's next earnings date?

DENTSPLY SIRONA is scheduled to release its next quarterly earnings announcement on Friday, August 7th 2020. View our earnings forecast for DENTSPLY SIRONA.

How were DENTSPLY SIRONA's earnings last quarter?

DENTSPLY SIRONA Inc (NASDAQ:XRAY) announced its earnings results on Friday, May, 8th. The medical instruments supplier reported $0.43 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.41 by $0.02. The medical instruments supplier earned $873.30 million during the quarter, compared to analysts' expectations of $873 million. DENTSPLY SIRONA had a return on equity of 10.70% and a net margin of 2.12%. DENTSPLY SIRONA's revenue was down 7.7% compared to the same quarter last year. During the same quarter last year, the firm posted $0.49 EPS. View DENTSPLY SIRONA's earnings history.

How often does DENTSPLY SIRONA pay dividends? What is the dividend yield for DENTSPLY SIRONA?

DENTSPLY SIRONA announced a quarterly dividend on Thursday, May 21st. Investors of record on Friday, June 26th will be paid a dividend of $0.10 per share on Friday, July 10th. This represents a $0.40 dividend on an annualized basis and a yield of 0.95%. The ex-dividend date is Thursday, June 25th. View DENTSPLY SIRONA's dividend history.

What guidance has DENTSPLY SIRONA issued on next quarter's earnings?

DENTSPLY SIRONA issued an update on its FY20 earnings guidance on Monday, March, 2nd. The company provided earnings per share guidance of $2.55-2.80 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.68. The company issued revenue guidance of $4.10-4.15 billion, compared to the consensus revenue estimate of $4.13 billion.

What price target have analysts set for XRAY?

12 brokers have issued twelve-month price targets for DENTSPLY SIRONA's shares. Their forecasts range from $38.00 to $66.00. On average, they expect DENTSPLY SIRONA's share price to reach $47.82 in the next twelve months. This suggests a possible upside of 13.2% from the stock's current price. View analysts' price targets for DENTSPLY SIRONA.

What are Wall Street analysts saying about DENTSPLY SIRONA stock?

Here are some recent quotes from research analysts about DENTSPLY SIRONA stock:

1. According to Zacks Investment Research, "DENTSPLY ended the third quarter on a solid note. Significant increase in the bottom line bodes well. The company gained from its core Technology & Equipment unit that witnessed year-over-year upside in the quarter. Overall sales grew on an internal basis. Internationally, revenues surged as well. The company raised earnings per share guidance, which indicates bright prospects. Product launches are encouraging. Significant expansion in margins is another positive. The stock has outperformed the industry in a year. Meanwhile, sales of Restorative and Endodontics products as well as Laboratory Dental products witnessed some softness in the quarter. Additionally, unfavorable foreign currency exchange and restructuring costs are expected to exert pressure on DENTSPLY SIRONA’s top line in 2019. The stock is overvalued at the moment." (12/10/2019)
2. Barrington Research analysts commented, "We are now modeling $2.35, up from our prior $2.32 estimate." (8/5/2019)

Has DENTSPLY SIRONA been receiving favorable news coverage?

News coverage about XRAY stock has been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies negative and positive news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. DENTSPLY SIRONA earned a coverage optimism score of -2.1 on InfoTrie's scale. They also assigned press coverage about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. View the latest news aboutDENTSPLY SIRONA.

Are investors shorting DENTSPLY SIRONA?

DENTSPLY SIRONA saw a increase in short interest in April. As of April 30th, there was short interest totaling 5,410,000 shares, an increase of 26.7% from the April 15th total of 4,270,000 shares. Based on an average daily volume of 2,580,000 shares, the days-to-cover ratio is currently 2.1 days. Approximately 2.5% of the shares of the company are sold short. View DENTSPLY SIRONA's Current Options Chain.

Who are some of DENTSPLY SIRONA's key competitors?

Some companies that are related to DENTSPLY SIRONA include Align Technology (ALGN), West Pharmaceutical Services (WST), Cooper Companies (COO), Quidel (QDEL), Haemonetics (HAE), ICU Medical (ICUI), Neogen (NEOG), Merit Medical Systems (MMSI), STAAR Surgical (STAA), Atrion (ATRI), Cerus (CERS), OraSure Technologies (OSUR), Meridian Bioscience (VIVO), Antares Pharma (ATRS) and Anika Therapeutics (ANIK). View all competitors.

What other stocks do shareholders of DENTSPLY SIRONA own?

Based on aggregate information from My MarketBeat watchlists, some companies that other DENTSPLY SIRONA investors own include NVIDIA (NVDA), Intel (INTC), QUALCOMM (QCOM), Gilead Sciences (GILD), IBM (IBM), Boeing (BA), General Electric (GE), Netflix (NFLX), Vertex Pharmaceuticals (VRTX) and Comcast (CMCSA).

Who are DENTSPLY SIRONA's key executives?

DENTSPLY SIRONA's management team includes the following people:

Mr. Nicholas William Alexos, Exec. VP & CFO (Age 55)
Mr. Keith John Ebling, EVP, Gen. Counsel & Sec. (Age 50)
Ms. Maureen J. MacInnis, Sr. VP, Chief HR Officer & Communications (Age 58)
Mr. Donald M. Casey Jr., CEO & Director (Age 59)
Mr. Dominique P. Legros, Sr. VP of Equipment, Technologies & Healthcare Segment (Age 59)

What is DENTSPLY SIRONA's stock symbol?

DENTSPLY SIRONA trades on the NASDAQ under the ticker symbol "XRAY."

Who are DENTSPLY SIRONA's major shareholders?

DENTSPLY SIRONA's stock is owned by a number of institutional and retail investors. Top institutional investors include BlackRock Inc. (7.22%), State Street Corp (4.47%), Janus Henderson Group PLC (3.40%), Atlanta Capital Management Co. L L C (3.29%), First Eagle Investment Management LLC (3.19%) and Nuance Investments LLC (2.60%). Company insiders that own DENTSPLY SIRONA stock include Betsy D Holden, Daniel P Key, Donald M Jr Casey, Eric Brandt, Gregory T Lucier, Markus Boehringer, Maureen J Macinnis, Michael C Alfano, Michael J Coleman and William E Newell. View institutional ownership trends for DENTSPLY SIRONA.

Which institutional investors are selling DENTSPLY SIRONA stock?

XRAY stock was sold by a variety of institutional investors in the last quarter, including Mackenzie Financial Corp, Morgan Stanley, Parnassus Investments CA, Korea Investment CORP, Invesco Ltd., Commerzbank Aktiengesellschaft FI, Credit Agricole S A, and Douglas Lane & Associates LLC. Company insiders that have sold DENTSPLY SIRONA company stock in the last year include Maureen J Macinnis, and Michael C Alfano. View insider buying and selling activity for DENTSPLY SIRONA.

Which institutional investors are buying DENTSPLY SIRONA stock?

XRAY stock was acquired by a variety of institutional investors in the last quarter, including Nuance Investments LLC, Wellington Management Group LLP, Janus Henderson Group PLC, Fiduciary Management Inc. WI, SG Americas Securities LLC, First Eagle Investment Management LLC, Atlanta Capital Management Co. L L C, and Nuveen Asset Management LLC. Company insiders that have bought DENTSPLY SIRONA stock in the last two years include Betsy D Holden, Daniel P Key, Donald M Jr Casey, and Gregory T Lucier. View insider buying and selling activity for DENTSPLY SIRONA.

How do I buy shares of DENTSPLY SIRONA?

Shares of XRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is DENTSPLY SIRONA's stock price today?

One share of XRAY stock can currently be purchased for approximately $42.24.

How big of a company is DENTSPLY SIRONA?

DENTSPLY SIRONA has a market capitalization of $9.25 billion and generates $4.03 billion in revenue each year. The medical instruments supplier earns $262.90 million in net income (profit) each year or $2.45 on an earnings per share basis. DENTSPLY SIRONA employs 15,200 workers across the globe.

What is DENTSPLY SIRONA's official website?

The official website for DENTSPLY SIRONA is www.dentsplysirona.com.

How can I contact DENTSPLY SIRONA?

DENTSPLY SIRONA's mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier can be reached via phone at 844-546-3722 or via email at [email protected]

This page was last updated on 5/26/2020 by MarketBeat.com Staff